Product Name:4-(Trifluoromethyl)aniline

IUPAC Name:4-(trifluoromethyl)aniline

CAS:455-14-1
Molecular Formula:C7H6F3N
Purity:95%+
Catalog Number:CM253041
Molecular Weight:161.13

Packing Unit Available Stock Price($) Quantity
CM253041-1000g in stock ħƚ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:455-14-1
Molecular Formula:C7H6F3N
Melting Point:-
Smiles Code:C1=C(C(F)(F)F)C=CC(=C1)N
Density:
Catalog Number:CM253041
Molecular Weight:161.13
Boiling Point:190°C at 760 mmHg
MDL No:MFCD00064396
Storage:Keep in a tight container and store at ambient temperature

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Obicetrapib
The elevated low-density lipoprotein cholesterol (LDL-C) is a causal risk factor for atherosclerotic cardiovascular disease (ASCVD), and heterozygous familial hypercholesterolemia (HeFH). Cholesteryl ester transfer protein (CETP) transports cholesterol from good high-density lipoprotein cholesterol (HDL-C) to low-density lipoprotein cholesterol (LDL-C). NewAmsterdam’s Obicetrapib is a novel, selective CETP inhibitor to address the limitations of current treatments.
Obicetrapib is under investigation in phase III clinical trials as a monotherapy product, and in phase II studies as a fixed dose combination with Ezetimibe.